Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC33A1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANXA1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
FBXW11 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GAD1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
VCAN - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
DNAJC10 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
TMPO - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
APOBEC3B - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
MIR22 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC728093 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Profile neighbors
PAFAH1B1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
NPIPA5 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
RBP1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
CYP4F8 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
NUP160 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
TMEM80 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
MAGED1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on